Cardiac Marker Market
Global Cardiac Marker Market Size, Share & Trends Analysis Report By Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), And By Testing (Laboratory Testing and Point Of Care Testing) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global cardiac marker market is anticipated to grow at a considerable CAGR of 8.7% globally. A major factor for the rise in the global cardiac marker market is mainly considered to growing cardiovascular diseases in adults of all age groups. People globally are facing health issues which are mainly caused by unhealthy lifestyle, junk meals and increasing work & life stress. These conditions further lead to cardiac diseases, blood pressure problems, hypertension, etc. As per a report by India today, in the year 2021, 650 million people who are above the age of 18 are suffering from any kind of problem-related to obesity. For instance, in Feb 2022, the global sensor patch market which was around USD 72.9 million in 2018 is anticipated to grow at a considerable rate. Blood glucose sensor patches which measure the amount of oxygen in the blood are considered a driver for this market as they are also used in case of cardiac arrest which happens anytime. The global sensor patch market is anticipated to grow to USD 1633 million by 2026.
Impact of COVID-19 Pandemic on Global cardiac marker Market
The cardiac marker saw a significant drop in the market. The primary reason for this was people were not able to get themselves tested with biomarkers as hospitals were temporarily not operational during this period.
Segmental Outlook
The global cardiac marker market is segmented based on type, application, and location of testing. Based on type, the market is segmented into creatine kinase, troponins, myoglobin, ischemia modified albumin, and others. Based on the application, the market is sub-segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based on testing the market is sub-segmented into laboratory testing and point of care testing. Among the above-mentioned segments, the point of care testing is going to see considerable growth as the number of cardiac patients is increasing globally. In times of immediate cardiac arrest, there is emergency testing for such conditions. This condition is met by point of care testing.
Global Cardiac marker Market Share by Type, 2021 (%)
Troponin Segment is Anticipated to Hold a Prominent Share in the Global Cardiac Marker Market
Among type, troponin segment is anticipated to hold a prominent market share in the global cardiac marker market as the number of people affected by cardiovascular diseases is increasing at a considerable rate. Troponin is a widely and commonly used biomarker for tracking cardiac disease in the human body. When a patient gets into cardiac arrest, this protein immediately enters the bloodstream. A significant reason for testing troponin in cardiovascular conditions is when the human body gets into cardiac arrest, this biomarker stays for a long period as compared to another biomarker. In April 2021, a global leader in the pharmaceutical industry Roche announced five new uses using for two Elecsys biomarkers which include high-sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). The cTnT-hs is intended to support cardiovascular disease management and help clinicians diagnose heart attacks while NT-proBNP supports better management of heart failure.
Regional Outlooks
The global cardiac marker market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). If we consider the geographic part, north America is anticipated to lead the cardiac marker market in the coming years.
Global Cardiac Marker Market Growth, by Region 2022-2028
North America is Estimated to Hold the Major Share in the Global Cardiac marker Market
Geographically, it is anticipated that the major share of the market will be taken by North America and this region will lead during projected forecast. A major reason for this is the increase in the geriatric population in the North American region which is driving this market. It is seen that in the North American region, the number of people getting infected by cardiovascular disease and CVDs are increasing at a prominent rate. R&D activities are also a major driver in this market. For instance, in Feb 2022, two types of cardiac reader systems namely magnetic immuno-chromatographic assay and chemiluminescence immunoassay analyzers are anticipated to hold a major portion of 40% revenue share in the global cardiac reader system sales.
Market Players Outlook
The major companies serving the global Cardiac marker market include Roche Diagnostics Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corp., Bio Merieux SA, and others. The market players are working in a consistent way to provide their consumers with recent and advanced options for Cardiac biomarker testing. For instance, in Jan 2020, in the field of recent development, research activities in the global cardiac marker market, Abbott laboratories, Roche diagnostics, and biomrieux are at the top as leading global vendors. They are consistently working in the area of troponin enhanced biomarker testing.
The Report Covers
- Market value data analysis of 2020 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Cardiac Marker market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Cardiac marker Market
• Recovery Scenario of Global Cardiac marker Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Roche Diagnostics Ltd.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Abbott laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Siemens Healthineers AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Danaher Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Bio merieux SA
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Cardiac markers Market by Type
4.1.1. Creatine Kinase (CK-MB)
4.1.2. Troponins (T,I)
4.1.3. Myoglobin
4.1.4. Ischemia Modified Albumin
4.1.5. Others
4.2. Global Cardiac markers Market by Application
4.2.1. Myocardial Infarction
4.2.2. Congestive heart failure
4.2.3. Acute coronary syndrome
4.2.4. Atherosclerosis
4.3. Global Cardiac markers Market by Testing
4.3.1. Laboratory testing
4.3.2. Point of care testing
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. LSI Medience Corporation
6.2. Ortho Clinical Diagnostics
6.3. Randox laboratories Ltd.
6.4. Guangzhou Wondfo Biotech Co.,Ltd
6.5. Diasorin S.p.A
6.6. Becton, Dickinson and Company
6.7. Bio-Rad laboratories, Inc.
6.8. Perkin Elmer Inc.
6.9. Thermo fisher scientific Inc.
6.10. Tosoh corporation
6.11. BG Medicine
6.12. Dia Dexus Biotechnology Co
6.13. Trinity Biotech
6.14. Thermo Fisher Scientific
6.15. HyTest Ltd.
1. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL TROPONINS CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL MYOGLOBIN CARDIAC MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
8. GLOBAL MYOCARDIAL INFARCTION CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL CONGESTIVE HEART FAILURE CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL ACUTE CORONARY SYNDROME CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL ATHEROSCLEROSIS CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL OTHER CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
14. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL POINT OF CARE TESTING MARKER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. NORTH AMERICAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
21. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
23. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
24. EUROPEAN CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS TYPE, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
29. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
30. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
31. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
32. REST OF THE WORLD CARDIAC MARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL CARDIAC MARKER MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL CARDIAC MARKER MARKET, 2021-2027 (%)
4. GLOBAL CARDIAC MARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL CREATINE KINASE CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL TROPONINS CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL MYOGLOBIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL ISCHEMIA MODIFIED ALBUMIN CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OTHER CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL CARDIAC MARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL MYOCARDIAL INFARCTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL CONGESTIVE HEART FAILURE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL CORONARY SYNDROME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL ATHEROSCLEROSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL CARDIAC MARKER MARKET SHARE BY LOCATION OF TESTING, 2021 VS 2028 (%)
17. GLOBAL LABORATORY TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL POINT OF CARE TESTING CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL CARDIAC MARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. US CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
21. CANADA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
22. UK CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
23. FRANCE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
24. GERMANY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
25. ITALY CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
26. SPAIN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF EUROPE CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
28. INDIA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
29. CHINA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
30. JAPAN CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
31. SOUTH KOREA CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF THE WORLD CARDIAC MARKER MARKET SIZE, 2021-2028 ($ MILLION)
